{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:39:00Z","timestamp":1790948340909,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pretherapeutic sex-specific basal calcitonin (bCt) cutoff levels and intraoperative diagnosis of desmoplastic stroma reaction (DSR) by frozen section independently facilitate the prediction of lymph-node metastases (LNM) and long-term outcomes in patients with medullary thyroid cancer (MTC). The relevance of combining these two parameters to \u201ctailor\u201d lymph-node (LN) surgery has thus far not been analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>This single-center analysis included 306 patients covered by a calcitonin screening program. A uniform surgical protocol [thyroidectomy, bilateral central neck dissection (CND), lateral neck dissection (LND)] was applied. Risk groups were subdivided on the basis of predefined bCt cutoffs (\u201cminimal risk,\u201d \u201clow risk,\u201d and \u201chigh risk\u201d), and the intraoperative classification of DSR was correlated with LN involvement in each patient. Biochemical long-term outcomes (mean follow-up: 8.3 years) were documented with the endpoints \u201cdisease-free,\u201d \u201cpersistent,\u201d or \u201crecurrent\u201d disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Patients in the \u201cminimal risk\u201d group (37.6%) and \u201clow risk\u201d group (16.3%) showed central but never lateral LNM in 2.6% and 6.0% of patients, respectively (cure rate: 98.2%). In the \u201chigh risk\u201d group (46.1%), LNM (central and\/or lateral) were found in 51.1% of the patients (cure rate: 60.9%). In all risk groups, DSR negativity (overall 20.6%) confirmed absence of LNM (cure rate:100%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The analysis facilitates the recommendation to individualize the extent of LND combining pretherapeutic bCt and the presence of DSR. Independent of bCt levels (risk groups), LND can be avoided following thyroidectomy in patients with DSR-negative tumors. Patients with DSR-positive tumors should undergo thyroidectomy and bilateral CND. In addition, in \u201chigh risk\u201d patients, unilateral LND is recommended in those with bCt &lt; 350 pg\/mL. Bilateral LND should be discussed in patients with M0 status and bCt &gt; 350 pg\/mL.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1245\/s10434-025-16958-x","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T15:23:41Z","timestamp":1741274621000},"page":"4742-4753","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tailored Surgery for Medullary Thyroid Cancer (MTC) Based on Pretherapeutic Basal Calcitonin and Intraoperative Diagnosis of Desmoplastic Stroma Reaction: A Proposal for a New Surgical Concept"],"prefix":"10.1245","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0450-6132","authenticated-orcid":false,"given":"Martin B.","family":"Niederle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Binter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Riss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Niederle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Scheuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"issue":"6","key":"16958_CR1","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00000658-199906000-00016","volume":"229","author":"JF Moley","year":"1999","unstructured":"Moley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg. 1999;229(6):880\u20137.","journal-title":"Ann Surg."},{"issue":"5","key":"16958_CR2","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1210\/jc.2002-021713","volume":"88","author":"C Scollo","year":"2003","unstructured":"Scollo C, Baudin E, Travagli JP, et al. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab. 2003;88(5):2070\u20135.","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"16958_CR3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.metabol.2010.06.004","volume":"60","author":"H Karga","year":"2011","unstructured":"Karga H, Giagourta I, Papaioannou G, et al. Changes in risk factors and tumor node metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin. Metabolism. 2011;60(5):604\u20138.","journal-title":"Metabolism."},{"issue":"2","key":"16958_CR4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jso.24126","volume":"113","author":"H Kwon","year":"2016","unstructured":"Kwon H, Kim WG, Sung TY, et al. Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma. J Surg Oncol. 2016;113(2):152\u20138.","journal-title":"J Surg Oncol."},{"issue":"5","key":"16958_CR5","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/cen.15041","volume":"100","author":"O Cohen","year":"2024","unstructured":"Cohen O, Tzelnick S, Randolph G, et al. Initial surgical management of sporadic medullary thyroid cancer: guidelines based optimal care - A systematic review. Clin Endocrinol (Oxf). 2024;100(5):468\u201376.","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"19","key":"16958_CR6","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.3390\/cancers16193343","volume":"16","author":"MB Niederle","year":"2024","unstructured":"Niederle MB, Binter T, Riss P, Niederle B, Scheuba C. The value of pretherapeutic basal calcitonin cut-offs for the therapeutic strategy and prediction of long-term outcome of patients with medullary thyroid cancer\u2014A 30-year single-center experience. Cancers. 2024;16(19):3343.","journal-title":"Cancers"},{"issue":"7","key":"16958_CR7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1089\/thy.2019.0785","volume":"30","author":"MB Niederle","year":"2020","unstructured":"Niederle MB, Scheuba C, Riss P, Selberherr A, Koperek O, Niederle B. Early Diagnosis of medullary thyroid cancer: are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays? Thyroid. 2020;30(7):974\u201384.","journal-title":"Thyroid."},{"issue":"2","key":"16958_CR8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/bjs\/znaa047","volume":"108","author":"MB Niederle","year":"2021","unstructured":"Niederle MB, Riss P, Selberherr A, et al. Omission of lateral lymph node dissection in medullary thyroid cancer without a desmoplastic stromal reaction. Br J Surg. 2021;108(2):174\u201381.","journal-title":"Br J Surg."},{"issue":"5","key":"16958_CR9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00268-005-0391-4","volume":"30","author":"C Scheuba","year":"2006","unstructured":"Scheuba C, Kaserer K, Kaczirek K, Asari R, Niederle B. Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative \u201cmarker\u201d for lymph node metastases. World J Surg. 2006;30(5):853\u20139.","journal-title":"World J Surg."},{"issue":"11","key":"16958_CR10","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1089\/thy.2005.15.1267","volume":"15","author":"H Vierhapper","year":"2005","unstructured":"Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S. Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid. 2005;15(11):1267\u201372.","journal-title":"Thyroid."},{"issue":"5","key":"16958_CR11","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1210\/jcem.82.5.3949","volume":"82","author":"H Vierhapper","year":"1997","unstructured":"Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhausl A, Niederle B. Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab. 1997;82(5):1589\u201393.","journal-title":"J Clin Endocrinol Metab."},{"key":"16958_CR12","doi-asserted-by":"crossref","first-page":"1278816","DOI":"10.3389\/fonc.2024.1278816","volume":"14","author":"P Trimboli","year":"2024","unstructured":"Trimboli P, Peloni G, Confalonieri D, et al. Determinants of circulating calcitonin value: analysis of thyroid features, demographic data, anthropometric characteristics, comorbidities, medications, and smoking habits in a population with histological full exclusion of medullary thyroid carcinoma. Front Oncol. 2024;14:1278816.","journal-title":"Front Oncol."},{"issue":"13","key":"16958_CR13","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1245\/s10434-018-6829-3","volume":"25","author":"L Brammen","year":"2018","unstructured":"Brammen L, Niederle MB, Riss P, et al. Medullary thyroid carcinoma: do ultrasonography and F-DOPA-PET-CT influence the initial surgical strategy? Ann Surg Oncol. 2018;25(13):3919\u201327.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"16958_CR14","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4158\/EP13143.OR","volume":"19","author":"GF Essig Jr","year":"2013","unstructured":"Essig GF Jr, Porter K, Schneider D, et al. Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone. Endocr Pract. 2013;19(6):920\u20137.","journal-title":"Endocr Pract."},{"issue":"3","key":"16958_CR15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00428-018-2303-7","volume":"472","author":"S Aubert","year":"2018","unstructured":"Aubert S, Berdelou A, Gnemmi V, et al. Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement. Virchows Arch. 2018;472(3):461\u20138.","journal-title":"Virchows Arch."},{"issue":"4","key":"16958_CR16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/(SICI)1097-0215(19960822)69:4<312::AID-IJC13>3.0.CO;2-7","volume":"69","author":"M Fink","year":"1996","unstructured":"Fink M, Weinhusel A, Niederle B, Haas OA. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. Study Group Multiple Endocrine Neoplasia Austria (SMENA). Int J Cancer. 1996;69(4):312\u20136.","journal-title":"Int J Cancer."},{"key":"16958_CR17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-3-319-22542-5_6","volume":"204","author":"K Frank-Raue","year":"2015","unstructured":"Frank-Raue K, Raue F. Hereditary medullary thyroid cancer genotype-phenotype correlation. Recent Results Cancer Res. 2015;204:139\u201356.","journal-title":"Recent Results Cancer Res."},{"issue":"7","key":"16958_CR18","first-page":"267","volume":"114","author":"C Bieglmayer","year":"2002","unstructured":"Bieglmayer C, Scheuba C, Niederle B, Flores J, Vierhapper H. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin. Wien Klin Wochenschr. 2002;114(7):267\u201373.","journal-title":"Wien Klin Wochenschr."},{"issue":"5","key":"16958_CR19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1515\/CCLM.2007.124","volume":"45","author":"C Bieglmayer","year":"2007","unstructured":"Bieglmayer C, Vierhapper H, Dudczak R, Niederle B. Measurement of calcitonin by immunoassay analyzers. Clin Chem Lab Med. 2007;45(5):662\u20136.","journal-title":"Clin Chem Lab Med."},{"issue":"9","key":"16958_CR20","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1373\/clinchem.2016.270009","volume":"63","author":"GJ Kahaly","year":"2017","unstructured":"Kahaly GJ, Algeciras-Schimnich A, Davis TE, et al. United States and European multicenter prospective study for the analytical performance and clinical validation of a novel sensitive fully automated immunoassay for calcitonin. Clin Chem. 2017;63(9):1489\u201396.","journal-title":"Clin Chem."},{"issue":"3","key":"16958_CR21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00423-013-1057-6","volume":"398","author":"H Dralle","year":"2013","unstructured":"Dralle H, Musholt TJ, Schabram J, et al. German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg. 2013;398(3):347\u201375.","journal-title":"Langenbecks Arch Surg."},{"issue":"9","key":"16958_CR22","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1365-2168.2002.02160.x","volume":"89","author":"H Dralle","year":"2002","unstructured":"Dralle H. Lymph node dissection and medullary thyroid carcinoma. Br J Surg. 2002;89(9):1073\u20135.","journal-title":"Br J Surg."},{"issue":"5","key":"16958_CR23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archotol.134.5.536","volume":"134","author":"KT Robbins","year":"2008","unstructured":"Robbins KT, Shaha AR, Medina JE, et al. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008;134(5):536\u20138.","journal-title":"Arch Otolaryngol Head Neck Surg."},{"issue":"12","key":"16958_CR24","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1245\/s10434-016-5338-5","volume":"23","author":"A Selberherr","year":"2016","unstructured":"Selberherr A, Riss P, Scheuba C, Niederle B. Prophylactic, \u201cfirst-step\u201d central neck dissection (level 6) does not increase morbidity after (total) thyroidectomy. Ann Surg Oncol. 2016;23(12):4016\u201322.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"16958_CR25","first-page":"274","volume":"114","author":"K Kaserer","year":"2002","unstructured":"Kaserer K, Scheuba C, Neuhold N, Weinhausel A, Vierhapper H, Niederle B. Recommendations for reporting C cell pathology of the thyroid. Wien Klin Wochenschr. 2002;114(7):274\u20138.","journal-title":"Wien Klin Wochenschr."},{"issue":"5","key":"16958_CR26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2559.2008.03002.x","volume":"52","author":"O Koperek","year":"2008","unstructured":"Koperek O, Scheuba C, Cherenko M, et al. Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential. Histopathology. 2008;52(5):623\u201330.","journal-title":"Histopathology."},{"issue":"6","key":"16958_CR27","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.surg.2007.09.016","volume":"142","author":"C Scheuba","year":"2007","unstructured":"Scheuba C, Kaserer K, Bieglmayer C, et al. Medullary thyroid microcarcinoma recommendations for treatment - a single-center experience. Surgery. 2007;142(6):1003\u201310.","journal-title":"Surgery."},{"issue":"1","key":"16958_CR28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/ERC-08-0059","volume":"16","author":"C Scheuba","year":"2009","unstructured":"Scheuba C, Kaserer K, Moritz A, et al. Sporadic hypercalcitoninemia: clinical and therapeutic consequences. Endocr Relat Cancer. 2009;16(1):243\u201353.","journal-title":"Endocr Relat Cancer."},{"key":"16958_CR29","unstructured":"Brierley J, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. Eighth edition. ed. Chichester, West Sussex, UK ; Hoboken, NJ: John Wiley & Sons, Inc.; 2017."},{"issue":"1","key":"16958_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, et al. Overview of the 2022 WHO Classification of thyroid neoplasms. Endocr Pathol. 2022;33(1):27\u201363.","journal-title":"Endocr Pathol."},{"issue":"6","key":"16958_CR31","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1210\/jc.2009-2368","volume":"95","author":"A Machens","year":"2010","unstructured":"Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab. 2010;95(6):2655\u201363.","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"16958_CR32","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.surg.2011.09.043","volume":"150","author":"DT Yip","year":"2011","unstructured":"Yip DT, Hassan M, Pazaitou-Panayiotou K, et al. Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma. Surgery. 2011;150(6):1168\u201377.","journal-title":"Surgery."},{"issue":"11","key":"16958_CR33","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1089\/thy.2016.0255","volume":"26","author":"GF Essig Jr","year":"2016","unstructured":"Essig GF Jr, Porter K, Schneider D, et al. Multifocality in sporadic medullary thyroid carcinoma: an international multicenter study. Thyroid. 2016;26(11):1563\u201372.","journal-title":"Thyroid."},{"issue":"6","key":"16958_CR34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567\u2013610.","journal-title":"Thyroid."},{"issue":"14","key":"16958_CR35","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.3390\/cancers13143379","volume":"13","author":"A Bove","year":"2021","unstructured":"Bove A, Farrukh M, Di Gioia A, et al. Surgical skills and technological advancements to avoid complications in lateral neck dissection for differentiated thyroid cancer. Cancers (Basel). 2021;13(14):3379.","journal-title":"Cancers (Basel)."},{"issue":"2","key":"16958_CR36","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1210\/jcem.85.2.6556","volume":"85","author":"R Cohen","year":"2000","unstructured":"Cohen R, Campos JM, Salaun C, et al. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d\u2019Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab. 2000;85(2):919\u201322.","journal-title":"J Clin Endocrinol Metab."},{"key":"16958_CR37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/CMAR.S440477","volume":"16","author":"S Liu","year":"2024","unstructured":"Liu S, Zhao H, Li X. Serum biochemical markers for medullary thyroid carcinoma: an update. Cancer Manag Res. 2024;16:299\u2013310.","journal-title":"Cancer Manag Res."},{"issue":"10","key":"16958_CR38","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.3390\/cancers12102894","volume":"12","author":"H Park","year":"2020","unstructured":"Park H, Park J, Choi MS, et al. Preoperative serum calcitonin and its correlation with extent of lymph node metastasis in medullary thyroid carcinoma. Cancers (Basel). 2020;12(10):2894.","journal-title":"Cancers (Basel)."},{"issue":"5","key":"16958_CR39","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1210\/jc.2011-2534","volume":"97","author":"A Machens","year":"2012","unstructured":"Machens A, Dralle H. Biological relevance of medullary thyroid microcarcinoma. J Clin Endocrinol Metab. 2012;97(5):1547\u201353.","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"16958_CR40","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1245\/s10434-021-09683-8","volume":"28","author":"PM Spanheimer","year":"2021","unstructured":"Spanheimer PM, Ganly I, Chou JF, et al. Prophylactic lateral neck dissection for medullary thyroid carcinoma is not associated with improved survival. Ann Surg Oncol. 2021;28(11):6572\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"16958_CR41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.surg.2021.04.052","volume":"171","author":"T Szabo Yamashita","year":"2022","unstructured":"Szabo Yamashita T, Rogers RT, Foster TR, et al. Medullary thyroid cancer: what is the optimal management of the lateral neck in a node negative patient at index operation? Surgery. 2022;171(1):177\u201381.","journal-title":"Surgery."},{"issue":"10","key":"16958_CR42","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/00000478-200110000-00004","volume":"25","author":"K Kaserer","year":"2001","unstructured":"Kaserer K, Scheuba C, Neuhold N, et al. Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol. 2001;25(10):1245\u201351.","journal-title":"Am J Surg Pathol."},{"key":"16958_CR43","unstructured":"Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J. WHO classification of tumours of endocrine organs. International agency for research on cancer (IARC); 2017."},{"issue":"8","key":"16958_CR44","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/bjs\/znad172","volume":"110","author":"J Gomez-Ramirez","year":"2023","unstructured":"Gomez-Ramirez J, Luengo P, Mercader E, et al. Desmoplastic reaction in medullary thyroid carcinoma predicts presence of lymph node metastasis. Br J Surg. 2023;110(8):1011\u20132.","journal-title":"Br J Surg."},{"issue":"2","key":"16958_CR45","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.surg.2021.07.035","volume":"171","author":"A Machens","year":"2022","unstructured":"Machens A, Kaatzsch P, Lorenz K, et al. Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer. Surgery. 2022;171(2):360\u20137.","journal-title":"Surgery."},{"issue":"6","key":"16958_CR46","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.surg.2023.09.003","volume":"174","author":"H Dralle","year":"2023","unstructured":"Dralle H, Brandenburg T, Weber F, et al. Sporadic noninvasive medullary thyroid neoplasm: a desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy. Surgery. 2023;174(6):1356\u201362.","journal-title":"Surgery"},{"issue":"3","key":"16958_CR47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamaoto.2023.4376","volume":"150","author":"YV Mao","year":"2024","unstructured":"Mao YV, Hughes EG, Steinmetz D, et al. Extent of surgery for medullary thyroid cancer and prevalence of occult contralateral foci. JAMA Otolaryngol Head Neck Surg. 2024;150(3):209\u201314.","journal-title":"JAMA Otolaryngol Head Neck Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-16958-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-16958-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-16958-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:58:37Z","timestamp":1748869117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-16958-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["16958"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-16958-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare. This paper is not based on previous communications to societies or meetings.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"Informed consent for all diagnostic and therapeutic procedures was obtained from each patient, adhering to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The Ethics Committee of the Medical University of Vienna approved the standard operating procedures (SOP), including all diagnostic and therapeutic procedures, the analysis of the patients\u2019 records, and the collection of data (EK 1506\/2014; EK 1583\/2019 version 7).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board statement"}}]}}